Expression of hsv1-miR-H18 and hsv2-miR-H9 as a field defect marker for detecting prostate cancer

BACKGROUND: Prostate-specific antigen (PSA) is a marker of prostate cancer (PCa), although its efficacy as a diagnostic marker remains controversial. A high false-positive rate leads to repeat biopsy in approximately 70% of patients, which may not be necessary. Epigenetic biomarkers of field canceri...

Descripción completa

Detalles Bibliográficos
Autores principales: Byun, Young Joon, Kang, Ho Won, Piao, Xuan-Mei, Zheng, Chuang-Ming, Moon, Sung-Kwon, Choi, Yung Hyun, Kim, Won Tae, Lee, Sang-Cheol, Yun, Seok Joong, Kim, Wun-Jae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Pacific Prostate Society 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804185/
https://www.ncbi.nlm.nih.gov/pubmed/35155300
http://dx.doi.org/10.1016/j.prnil.2021.11.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804185/
https://www.ncbi.nlm.nih.gov/pubmed/35155300
http://dx.doi.org/10.1016/j.prnil.2021.11.003

Ejemplares similares